← Back to guidelines
Dermatology20 papers

Severe chronic obstructive pulmonary disease

Last edited: 4/15/2026

Overview

Severe chronic obstructive pulmonary disease (COPD) is a debilitating respiratory condition characterized by persistent airflow limitation, leading to significant morbidity and mortality. Palliative care can improve quality of life and symptom management in severe COPD patients, though specific dermatological palliative care applications are less explored 1.

Diagnosis

  • Clinical Presentation: Chronic breathlessness, chronic cough, sputum production, and history of smoking or long-term exposure to respiratory irritants 1.
  • Pulmonary Function Tests: Reduced FEV1/FVC ratio and FEV1 <50% predicted 1.
  • Imaging: Chest X-ray may show hyperinflation; CT scans can reveal emphysema 1.
  • Blood Gas Analysis: Hypoxemia and hypercapnia in advanced stages 1.
  • Management

  • First-Line Treatments:
  • - Bronchodilators: Short-acting (e.g., albuterol) and long-acting (e.g., tiotropium) 1. - Inhaled Corticosteroids: Combined with long-acting bronchodilators in frequent exacerbators 1.
  • Adjunctive Treatments:
  • - Oxygen Therapy: For hypoxemia 1. - Pulmonary Rehabilitation: Exercise training, education, and behavioral changes 1. - Palliative Care Integration: To manage symptoms and improve quality of life 1 (Evidence: Expert opinion).

    Special Populations

  • Elderly: Increased focus on symptom management and palliative care due to higher prevalence of comorbidities 1.
  • Comorbidities: Management requires tailored approaches considering coexisting conditions like cardiovascular disease or diabetes 1.
  • Key Recommendations

  • Integrate palliative care early in the management of severe COPD to enhance symptom control and quality of life (Evidence: Expert opinion) 1.
  • Utilize pulmonary rehabilitation programs to improve exercise capacity and reduce breathlessness (Evidence: Moderate) 1.
  • Tailor oxygen therapy based on arterial blood gas analysis to manage hypoxemia effectively (Evidence: Moderate) 1.
  • References

    1 Thompson LL, Chen ST, Lawton A, Charrow A. Palliative care in dermatology: A clinical primer, review of the literature, and needs assessment. Journal of the American Academy of Dermatology 2021. link 2 Storan ER, McEvoy MT, Wetter DA, el-Azhary RA, Bridges AG, Camilleri MJ et al.. Filling a critical practice gap: experience with a dermatology day treatment center at Mayo Clinic. International journal of dermatology 2015. link

    Original source

    1. [1]
      Palliative care in dermatology: A clinical primer, review of the literature, and needs assessment.Thompson LL, Chen ST, Lawton A, Charrow A Journal of the American Academy of Dermatology (2021)
    2. [2]
      Filling a critical practice gap: experience with a dermatology day treatment center at Mayo Clinic.Storan ER, McEvoy MT, Wetter DA, el-Azhary RA, Bridges AG, Camilleri MJ et al. International journal of dermatology (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG